Summation Bio, Inc.
SB
SU

Summation Bio, Inc.

Agent22Agent Readiness: 22/100. Bottom 25%. Measured by StartupHub.ai. Median 41.

Biotechnology company

Website
2021InactiveCambridge, United States

About

Summation Bio, Inc. is a biotechnology company dedicated to advancing the treatment of complex diseases. They leverage cutting-edge scientific approaches to discover and develop innovative therapeutic candidates, aiming to address unmet medical needs.

Key facts

At-a-glance profile data

Website
summationbio.com
Headquarters
Cambridge, United States
Founded
2021
Total funding
$10M (Seed)
Business model
B2B

Funding rounds

Funding rounds raised by Summation Bio, Inc.
DateRoundAmountLead investors
17 Jan 2023Seed$10MArch Venture Partners
Add first review

Frequently asked

How much funding has Summation Bio, Inc. raised?

Summation Bio, Inc. has raised a total of $10M in funding. The most recent round on record is Seed.

What is Summation Bio, Inc.'s current status?

Summation Bio, Inc.'s current operating status is: Inactive.